Literature DB >> 16767397

Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy.

Jeroen S Goede1, Rudolf Benz, Joerg Fehr, Klaus Schwarz, Hermann Heimpel.   

Abstract

Congenital dyserythropoietic anemia type I (CDA I) is a rare autosomal recessive disorder with ineffective erythropoiesis, characteristic morphological abnormalities of erythroblasts, and iron overloading. CDA I is caused by mutations in the CDAN I gene, encoding a protein named codanin-1. Complex bone abnormalities, especially syndactyly, have not been systematically described with this disease. We present two cases of morphologically and genetically confirmed CDA I with striking bone abnormalities and response to treatment with alpha-interferon. Our cases clearly document the association of skeletal anomalism with CDA I and indicate that codanin-1 may play a role in the development of the skeleton.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767397     DOI: 10.1007/s00277-006-0143-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  5 in total

1.  Stem cell transplantation for congenital dyserythropoietic anemia: an analysis from the European Society for Blood and Marrow Transplantation.

Authors:  Maurizio Miano; Dirk-Jan Eikema; Mahmoud Aljurf; Pieter J Van't Veer; Gülyüz Öztürk; Matthias Wölfl; Frans Smiers; Angsar Schulz; Gerard Socié; Kim Vettenranta; Cristina Diaz de Heredia; Marco Zecca; Johan Maertens; Montserrat Rovira; Jorge Sierra; Duygu Uckan-Cetinkaya; Elena Skorobogatova; Ali Bülent Antmen; Jean-Hugues Dalle; Miroslaw Markiewicz; Rose Marie Hamladji; Vassiliki Kitra-Roussou; Giorgio La Nasa; Gergely Kriván; Amal Al-Seiraihy; Stefano Giardino; Antonio Maria Risitano; Regis Peffault de Latour; Carlo Dufour
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

2.  Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha.

Authors:  Ayse Salihoglu; Tugrul Elverdi; Ahmet Emre Eskazan; Deniz Eyice; Isil Bavunoglu; Muhlis Cem Ar; Seniz Ongoren; Elif Guzel; Zafer Baslar; Aydin Tunckale; Nukhet Tuzuner; Teoman Soysal
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-21       Impact factor: 0.900

3.  Congenital dyserythropoietic anemia.

Authors:  Takahiro Kamiya; Atsushi Manabe
Journal:  Int J Hematol       Date:  2010-09-07       Impact factor: 2.490

4.  Neonatal cholestasis and hepatosplenomegaly caused by congenital dyserythropoietic anemia type 1: A case report.

Authors:  Catalina Jaramillo; Anna K Ermarth; Angelica R Putnam; Mark Deneau
Journal:  World J Hepatol       Date:  2019-05-27

Review 5.  The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I.

Authors:  Noémi B A Roy; Christian Babbs
Journal:  Br J Haematol       Date:  2019-03-05       Impact factor: 6.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.